Bill
HB 2600
Prohibits state employers from mandating EUA COVID-19 vaccines or proof of vaccination; takes effect immediately, with unclear enforcement and no listed exceptions yet.
Note on source material
- The materials provided appear to include text from two different HB 2600 drafts: (1) an Arizona technical renumbering/amendment concerning the Department of Child Safety and termination/repeal dates, and (2) an Illinois bill titled the "COVID-19 Vaccination Employer Mandate Prohibition Act." This summary focuses on the COVID-19 vaccine mandate prohibition (the item titled “PROHIBIT COVID-19 VAX MANDATE”), which matches the requested topic.
Purpose
- The bill’s stated purpose is to preserve individual bodily autonomy by prohibiting employers from requiring employees to receive or to prove receipt of COVID-19 vaccines or related boosters that are authorized for use under the FDA’s Emergency Use Authorization (EUA) mechanism (referencing Section 564 of the Federal Food, Drug, and Cosmetic Act).
Key provisions
- Short title: COVID-19 Vaccination Employer Mandate Prohibition Act.
- Prohibition: Makes it unlawful for any employer in the State to create, implement, or otherwise enforce a workplace vaccination program that requires an employee to demonstrate to the employer that they received a COVID-19 vaccine or booster that was authorized for emergency use by the U.S. Food and Drug Administration.
- Scope: The prohibition applies to employers in the state (text refers broadly to “an employer in this State”).
- Effective date: The Act takes effect immediately upon becoming law (language: “takes effect upon becoming law”).
What the bill does not specify (in the provided text)
- The draft does not identify enforcement mechanisms, civil or criminal penalties, private right of action, or administrative remedies for violations.
- It does not list exceptions or carve-outs (for example, for healthcare facilities, congregate care settings, federal contractors, or job roles with specific safety or federal requirements).
- It specifically targets vaccines “approved under emergency use authorization”; it does not explicitly address vaccines that later receive full FDA approval (thus, mandates for fully approved vaccines may not be covered by this prohibition).
Who would be affected
- Employers operating in the state (private and public) who might otherwise require COVID-19 vaccination or proof of vaccination as a condition of employment, hiring, or workplace access.
- Employees who would be required to show vaccination status under employer policies.
- Sectors with public-health-sensitive work (healthcare, long-term care, public safety, schools, higher education) could see immediate operational and policy impacts if they previously imposed vaccine mandates.
- Potential indirect effects on public health policy, workplace safety protocols, and employers’ liability exposures.
Potential impacts and considerations
- Employers cannot mandate or require proof of EUA-authorized COVID-19 vaccination for employees; they may need to rely on alternative safety measures (masking, testing, remote work).
- The bill may create tension or legal conflict with federal requirements (e.g., federal contractor rules or federal public-health directives) if such requirements exist and are applicable.
- Because the bill targets EUA-authorized vaccines, its applicability may change if a given vaccine receives full FDA approval.
- Absent specified enforcement provisions, remedies and compliance pathways could require later clarification or litigation.
Legislative status (from provided material)
- Introduced in early February 2025 (Illinois draft introduced 02/06/2025 by Rep. Adam M. Niemerg). The consolidated material also references Rep. Walt Blackman as a sponsor (likely reflecting the separate Arizona item). The bill has been referred to committee (Rules/State Affairs per differing entries).
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
